- Home
- FSEA vs PEPG Comparison
FSEA vs PEPG Comparison
Compare FSEA & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSEA
- PEPG
- Stock Information
- Founded
- FSEA 1890
- PEPG 2018
- Country
- FSEA United States
- PEPG United States
- Employees
- FSEA N/A
- PEPG N/A
- Industry
- FSEA Savings Institutions
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- FSEA Finance
- PEPG Health Care
- Exchange
- FSEA Nasdaq
- PEPG Nasdaq
- Market Cap
- FSEA 53.7M
- PEPG 45.9M
- IPO Year
- FSEA N/A
- PEPG 2022
- Fundamental
- Price
- FSEA $11.48
- PEPG $1.87
- Analyst Decision
- FSEA
- PEPG Buy
- Analyst Count
- FSEA 0
- PEPG 4
- Target Price
- FSEA N/A
- PEPG $7.25
- AVG Volume (30 Days)
- FSEA 2.4K
- PEPG 539.9K
- Earning Date
- FSEA 11-07-2025
- PEPG 11-06-2025
- Dividend Yield
- FSEA N/A
- PEPG N/A
- EPS Growth
- FSEA N/A
- PEPG N/A
- EPS
- FSEA N/A
- PEPG N/A
- Revenue
- FSEA $14,095,000.00
- PEPG N/A
- Revenue This Year
- FSEA N/A
- PEPG N/A
- Revenue Next Year
- FSEA N/A
- PEPG N/A
- P/E Ratio
- FSEA N/A
- PEPG N/A
- Revenue Growth
- FSEA 30.26
- PEPG N/A
- 52 Week Low
- FSEA $8.90
- PEPG $0.88
- 52 Week High
- FSEA $11.95
- PEPG $10.06
- Technical
- Relative Strength Index (RSI)
- FSEA 48.23
- PEPG 71.39
- Support Level
- FSEA $11.50
- PEPG $1.35
- Resistance Level
- FSEA $11.62
- PEPG $2.10
- Average True Range (ATR)
- FSEA 0.14
- PEPG 0.17
- MACD
- FSEA -0.02
- PEPG 0.06
- Stochastic Oscillator
- FSEA 18.59
- PEPG 76.29
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.